Injective (INJ) Surges 27.89% to Test $9.60 Resistance Level
Injective Protocol's native token INJ has surged over 27% in the past 24 hours, testing key resistance around $9.60.
Injective Protocol's native token INJ has surged over 27% in the past 24 hours, testing key resistance around $9.60. Injective (INJ) is trading at $9.18, down 0.9% since this brief published. This is an original TLT brief based on reporting by AMBCrypto, with live market data added, as of Fri, 16 Oct 2026 09:15:03 UTC.
The surge in INJ's price is significant as it tests a critical resistance level that could determine its next major price movement. A confirmed breakout above $9.60 could signal further upward momentum.
- INJ price has surged 27.89% in the past 24 hours.
- The token is testing the $9.60 resistance level.
- A breakout above $13.575 is needed for a long-term trend shift.
Injective (INJ) has seen a substantial price increase of 27.89% over the past 24 hours, bringing its current price to $9.26. This surge has brought the token close to a key resistance level at $9.60, which is being closely watched by traders and analysts.
The token has also performed well over the past week, with a 30.53% increase in its price. The market capitalization of Injective has grown to $925.87 million as a result of this recent price action.
While the 24-hour and 7-day performance of INJ is impressive, it is important to note that the broader crypto market is also experiencing a period of growth. The total crypto market cap has risen to $2.83 trillion, with 
Bitcoin up 1.14% in the last 24 hours.
The Fear & Greed Index currently stands at 63, indicating a sentiment of 'Greed' among investors. This positive market sentiment could be contributing to the strong performance of INJ and other cryptocurrencies.
Traders will be closely monitoring whether INJ can break through the $9.60 resistance level. If it does, this could signal further upward momentum. However, long-term investors will be looking for a more significant price increase to $13.575 to confirm a potential long-term trend shift.
Since this brief published about 1 hour ago, Injective (INJ) has moved from $9.26 to $9.18 — -0.86%.
The chart plots INJ's price: grey is the move before this brief published, the vertical dashed line marks the moment it published, the horizontal dashed line is the price then, and the coloured area is the move since — from TLT's market data (daily resolution). It shows what happened after the news, not that the news caused it; many factors move prices. Not financial advice.
At today's peer-to-peer rate, 1 INJ ≈ ₦12,534 (about $9.18), up 25.4% over 24 hours. The naira itself trades about 2.6% above the official rate on the P2P market, so a Nigerian buyer's effective cost differs from the headline dollar price.
Live market data
Current prices for the asset in this story — live, source-stamped, updated every 15 minutes.
Injective (INJ) Surges 27.89% to Test $9.60 Resistance Level — questions & answers
What is the current price of Injective (INJ)?
INJ is currently priced at $9.26, having surged 27.89% in the past 24 hours.
What resistance level is INJ approaching?
INJ is approaching the $9.60 resistance level, which is crucial for further upward movement.
What do long-term investors want to see?
Long-term investors are looking for INJ to surpass $13.575 to indicate a potential trend shift.
How much is 1 Injective worth in naira today?
About ₦12,534 at the live peer-to-peer (P2P) USDT rate, which is what Nigerians typically trade at — equivalent to roughly $9.18. The naira price moves with both INJ's US-dollar price and the USDT/NGN rate; use our Injective in naira page for any amount.
Has Injective's price moved since this brief was published?
INJ is down 0.86% since this brief first published — trading at $9.18 now versus $9.26 at publication. TLT re-checks this figure against CoinGecko and Binance every 15 minutes.
Which outlets reported this story?
This is an original TLT brief that synthesises reporting from AMBCrypto. It is not a copy of any one article — follow the source links above for the original reporting.
Original summary — not financial advice. This is an original TLT brief that summarises a development reported elsewhere and adds live market data for context; it is not the original article and reproduces no part of it. Follow the source link above for full details. Crypto is volatile and high-risk — always do your own research.